NewLimit develops age-reversing drug, human clinical trial set for 2027NewLimit has come up with a new anti-aging breakthrough by developing a drug that can reverse the aging in human cells. Founded by Brian Armstrong, the company has closed a $435 million Series C funding round led by Founders. ..



